Atopic Dermatitis Market Forecast to Hit USD 22.37 Billion by 2034 | CAGR: 8.5%

Atopic Dermatitis Market
The global atopic dermatitis market is projected to witness a growth rate of 8.5% from 2025 to 2034. It is projected to reach USD 22.37 billion by 2034 from USD 9.93 billion in 2024, according to an analysis by Polaris Market Research.

Market Outlook
Atopic dermatitis is a skin condition that causes dry, itchy, and inflamed skin. It is a normal affair in young children but can impact grown ups also. It is prolonged and is inclined to flare sometimes. It can be exasperating but is not contagious. People with atopic dermatitis have the probability of developing food susceptibilities, hay fever, and asthma. Moisturizing often and ensuing other skin care patterns can mitigate itching and prohibit contemporary outbreaks.

Several alternatives are available to assist regulate itching and mend the skin. Commodities are obtainable in several forms and as creams, gels and ointments. For a more developed eczema, the healthcare provider may prescribe pills to assist regulate the symptoms of eczema treatment.

Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/global-atopic-dermatitis-market-size/request-for-sample

Market Drivers
Growing Cases of Atopic Dermatitis: There is a growing aggregate of atopic dermatitis cases globally. As per the International Eczema Council, roughly 223 million persons globally were affected by atopic dermatitis in 2022. The growing existence underscores the rising demand for productive cures and handling schemes. Thus the growing existence of atopic dermatitis fuels the atopic dermatitis market demand.

Innovations in Biologic Cures: Inventions in biologic cures have transformed the therapeutic landscape for atopic dermatitis. Biotechnology and pharmaceutical firms are concentrating on advancing new therapeutic alternatives involving targeted biologics, miniature molecular inhibitors, and immunomodulators. These inventive drugs provide improved productivity and security profiles. Thus, the growing progression of biologics for atopic dermatitis drives the market growth.

Top Companies
The market is excessively competitive. Some of the key players in the market are:
• AbbVie Inc.
• Allergan plc
• Almirall, S.A.
• Astellas Pharma Inc.
• Bayer AG
• Eli Lilly and Company
• Galderma S.A.
• Incyte Corporation
• LEO Pharma A/S
• Novartis AG
• Pfizer Inc.
• Regeneron Pharmaceuticals, Inc.
• Sanofi S.A.

Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/global-atopic-dermatitis-market-size/request-for-discount-pricing

Atopic Dermatitis Industry Developments
• July 2024: Kymera Therapeutics, a clinical-stage biopharmaceutical company, announced that Sanofi would expand the Phase 2 trial of KT-474-an investigational therapy for autoimmune skin disorders including atopic dermatitis-after encouraging safety and efficacy data were observed during initial reviews.

• July 2024: Arcutis Biotherapeutics, Inc., a commercial-stage company specializing in immuno-dermatology, received approval from the U.S. Food and Drug Administration (FDA) for its supplemental new drug application (sNDA) for ZORYVE® (roflumilast) cream 0.15%. The cream is now approved for treating mild to moderate atopic dermatitis in adults and children aged six and older.

• January 2024: Glenmark Pharmaceuticals Ltd. partnered with Pfizer to introduce abrocitinib in India. This marks the launch of the first oral advanced systemic therapy for moderate-to-severe atopic dermatitis in the country, offering a novel treatment option for patients with inadequate response to topical therapies.

Atopic Dermatitis Market Report Highlights
• The atopic dermatitis market, by drug class, is segmented into biologics, calcineurin inhibitors, corticosteroids, PDE4 inhibitors, and others. The biologics segment accounted for a major market share in 2024.

• The market, by route of administration, is segmented into topical, injectable, and oral. The injectable segment dominated the atopic dermatitis market share in 2024. This dominance is largely attributed to the widespread adoption of injectable biologic therapies.

• North America accounted for a major share of the atopic dermatitis market revenue in 2024 due to the high prevalence of atopic dermatitis and substantial healthcare expenditures.

Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/global-atopic-dermatitis-market-size

Segment Insights
The atopic dermatitis market is segmented by drug class, route of administration, therapy, and region.

Based on drug class, the biologics segment accounted for a major market share in 2024 as progressive therapies such as interleukin inhibitors are usually prescribed for severe cases.

Based the route of administration, the injectable segment held the largest market share in 2024 due to the rising adoption of injectable biologic therapies, such as Dupilumab, which have been effective in handling ordinary to severe cases.

Atopic Dermatitis Market, Drug Class Outlook (Revenue - USD Billion, 2020-2034)
• Biologics
• Calcineurin Inhibitors
• Corticosteroids
• PDE4 Inhibitors
• Others

Atopic Dermatitis Market, Route of Administration Outlook (Revenue - USD Billion, 2020-2034)
• Topical
• Injectable
• Oral

Atopic Dermatitis Market, Therapy Outlook (Revenue - USD Billion, 2020-2034)
• Photo Therapy
• Directed Therapy

Regional Perspective
• North America
o US
o Canada
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Netherlands
o Russia
o Rest of Europe

More Trending Latest Reports by Polaris Market Research:
Background Music Market
https://www.polarismarketresearch.com/industry-analysis/background-music-market

Marine Seats Market
https://www.polarismarketresearch.com/industry-analysis/marine-seat-market

Zeolite Market
https://www.polarismarketresearch.com/industry-analysis/zeolite-market

Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.